EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 132 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $28,301,000 | +12.8% | 861,799 | +8.3% | 0.00% | 0.0% |
Q3 2016 | $25,092,000 | +2.9% | 795,824 | -8.2% | 0.00% | 0.0% |
Q2 2016 | $24,376,000 | -20.8% | 866,851 | +2.4% | 0.00% | -20.0% |
Q1 2016 | $30,775,000 | -10.4% | 846,625 | -1.3% | 0.01% | -16.7% |
Q4 2015 | $34,330,000 | +46.5% | 858,029 | +4.3% | 0.01% | +50.0% |
Q3 2015 | $23,432,000 | -21.9% | 822,480 | -9.6% | 0.00% | -20.0% |
Q2 2015 | $29,985,000 | +9.8% | 910,022 | -4.2% | 0.01% | +25.0% |
Q1 2015 | $27,317,000 | +5.7% | 949,819 | +0.1% | 0.00% | 0.0% |
Q4 2014 | $25,844,000 | +26.7% | 949,103 | -0.9% | 0.00% | +33.3% |
Q3 2014 | $20,404,000 | -7.9% | 957,498 | -3.0% | 0.00% | -25.0% |
Q2 2014 | $22,161,000 | -10.7% | 986,671 | +0.5% | 0.00% | 0.0% |
Q1 2014 | $24,807,000 | +11.7% | 981,671 | +1.7% | 0.00% | 0.0% |
Q4 2013 | $22,202,000 | +22.3% | 965,715 | +1.3% | 0.00% | 0.0% |
Q3 2013 | $18,161,000 | +36.1% | 953,324 | +3.0% | 0.00% | +33.3% |
Q2 2013 | $13,348,000 | – | 925,690 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Values First Advisors, Inc. | 152,699 | $519,178 | 0.34% |
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 299,187 | $1,017,000 | 0.22% |
Hilltop Holdings Inc. | 235,019 | $799,064 | 0.09% |
AIMZ Investment Advisors, LLC | 51,372 | $174,665 | 0.08% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 868,605 | $2,953,257 | 0.07% |
PALISADE CAPITAL MANAGEMENT, LP | 509,325 | $1,731,705 | 0.05% |
SHERBROOKE PARK ADVISERS LLC | 41,417 | $140,818 | 0.04% |
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 2,428,490 | $8,256,866 | 0.03% |
Y-Intercept (Hong Kong) Ltd | 75,362 | $256,231 | 0.02% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,246,020 | $4,236,468 | 0.02% |